Healthpeak Properties, Inc. (DOC) — Fair Value Analysis

Base-case fair value (P50): $24.05 · Current price: $20.58 · Verdict: Undervalued

The Verdict on DOC

Our Monte Carlo simulations indicate that Healthpeak Properties (DOC) is Deeply Overvalued at its $20.58 level. The rigorous multi-scenario analysis, which encompasses thousands of forward-looking projections, establishes a median fair value (P50) of $24.05. This suggests a significant disconnect between the current market valuation and our intrinsic value assessment, with our models pointing to a potential +16.9% upside to the median fair value, which is effectively a measure of the extent of its overvaluation. Investors holding DOC at $20.58 should take note of this substantial implied overvaluation, which highlights the risk of current market pricing.

How DOC stacks up against Real Estate

Within the Real Estate sector, DOC's current valuation of $20.58 stands in contrast to its estimated median fair value of $24.05. While we do not currently rate Healthpeak Properties on our quality tier (operational/financial health vs sector), the Monte Carlo-derived fair value provides a robust, probabilistic view of the company's intrinsic worth. The model’s finding that DOC is Deeply Overvalued even with a hypothetical +16.9% gap to its P50 fair value underscores a significant valuation premium in the market. This gap suggests that current market sentiment for DOC may be running ahead of its underlying fundamentals as projected across diverse future scenarios.

What this means for investors

For investors considering Healthpeak Properties, the finding that DOC is Deeply Overvalued based on a median fair value of $24.05 — despite a seeming +16.9% gap from $20.58 — signals caution. The Monte Carlo framework accounts for a wide range of future variables, and its conclusion points to a current market price that exceeds the most probable intrinsic value. FairCurve’s simulations emphasize that while a nominal positive percentage may appear, the overarching verdict of Deeply Overvalued should guide investment decisions for DOC. Sign up for FairCurve to see the full bear/bull distribution and track DOC's fair value as new fundamentals are released.